OR WAIT null SECS
January 04, 2021
Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.
The companies have entered into an agreement to support the formulation and fill/finish of Moderna’s COVID-19 vaccine supply outside of the United States.
Honeywell will use Sparta’s expertise to introduce new QMS solutions for life sciences to its customer base.
January 01, 2021
Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.
December 23, 2020
The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.
The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
The product represents a first-of-its-kind intentional genomic alteration in a line of domestic pigs that may be used for human therapeutics.
The films are now available in three options of varying thickness for added protection against moisture and oxygen.
The company has formed an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s COVID-19 vaccine candidate, to the people of Singapore.